Apimeds Pharmaceuticals US (APUS) vs Universe Pharmaceuticals (UPC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Universe Pharmaceuticals (UPC) has outperformed Apimeds Pharmaceuticals US (APUS) over the past year, losing 55.8% versus a loss of 70.5%. Universe Pharmaceuticals is the larger company by market cap ($21.0 million vs $8.3 million), about 2.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APUS | UPC |
|---|---|---|
| Share price | $5.51 | $4.18 |
| Market cap | $8.32M | $21.00M |
| 1-day change | -21.84% | -5.00% |
| YTD return | -66.40% | +9.71% |
| 1-year return | -70.53% | -55.81% |
| 5-year return | — | -99.95% |
| EPS (TTM) | $-36.03 | $-1.38 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $59.70 | $17.96 |
| 52-week low | $1.51 | $2.00 |
| Distance from 52-week high | -90.77% | -76.73% |
| Average volume | 3.66M | 788.87K |
| Shares outstanding | 1.51M | 5.01M |
| Employees | — | 216 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Universe Pharmaceuticals is about 2.5 times larger than Apimeds Pharmaceuticals US by market value ($21.00M vs $8.32M).
- UPC has outperformed APUS by 14.7 percentage points over the past year.
About Apimeds Pharmaceuticals US
APUS stock →Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure.
Healthcare · Drug Manufacturers - Specialty & Generic
About Universe Pharmaceuticals
UPC stock →Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.
Healthcare · Drug Manufacturers - Specialty & Generic · 216 employees
APUS vs UPC FAQ
Which is bigger, Apimeds Pharmaceuticals US or Universe Pharmaceuticals?
Universe Pharmaceuticals (UPC) is larger, with a market capitalization of $21.00M compared with $8.32M for Apimeds Pharmaceuticals US (APUS).
Which stock has performed better over the past year, APUS or UPC?
UPC returned -55.81% over the past 12 months, compared with -70.53% for APUS (price return, excluding dividends). Past performance does not predict future results.
Are Apimeds Pharmaceuticals US and Universe Pharmaceuticals in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.